Category Archives: Cardiac Surgery

Medical device An artificial cardiac pacemaker (or artificial pacemaker, so as not to be confused with the natural cardiac pacemaker) or pacemaker is a medical device that generates electrical impulses delivered by electrodes to the chambers of the heart either the upper atria, or lower ventricles to cause the targeted chambers to contract and pump blood.[3] By doing so, the pacemaker regulates the function of the electrical conduction system of the heart. The primary purpose of a pacemaker is to maintain an adequate heart rate, either because the heart's natural pacemaker is not fast enough, or because there is a block in the heart's electrical conduction system. Continue reading →

How long does it take to recover after cardiac bypass surgery? What should I eat after cardiac bypass surgery? Continue reading →

If you've had a heart attack, you may have already had certain procedures to help you survive your heart attack and diagnose your condition. For example, many heart attack patients have undergone thrombolysis, a procedure that involves injecting a clot-dissolving agent to restore blood flow in a coronary artery.This procedure is administered within a few (usually three) hours of a heart attack. Continue reading →

GRAND RAPIDS, MI After being the largest metropolitan city in the country with only one option for open-heart surgery, Grand Rapids area patients will now have another choice for their cardiovascular care. The Cardiovascular Network of West Michigan, made up of Trinity Health St. Marys. Continue reading →

Catholic Medical Center has hired an outside law firm with experience in the healthcare industry to review its cardiac surgery unit, following a Boston Globe Spotlight investigation that raised concerns about a former CMC surgeon with one of the countrys worst malpractice records. CMC announced Thursday that Pennsylvania-based firm Horty, Springer & Mattern will conduct an independent look at the hospitals credentialing practices and how leadership responded to employee concerns about Dr. Continue reading →

PRINCETON, N.J., Oct. 12, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced the presentation of exciting new data on the use of CytoSorb in various cardiac surgery indications at the 36th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting last week in Milan, Italy. Continue reading →

A new viral TikTok video by Dr. Karan Rajan tells the incredible story of a life-saving heart surgery performed on an unborn baby in the womb Continue reading →

Why an analysis of COVID-19 vaccines from Floridas surgeon general is flawed In a Dec.16, 2020 file photo, a Pfizer BioNTech COVID-19 vaccine is administered at the Arizona Department of Health Services State Laboratory in Phoenix. (AP) If youre a male Floridian between the ages of 18 and 39, recent news about the COVID-19 vaccines might have been alarming. Florida Surgeon General Dr. Continue reading →

BORDEAUX, France--(BUSINESS WIRE)--FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, today announced appointment of two experienced medical device experts to support the company's next clinical and industrial phases. "We are very proud to welcome two internationally renowned executives who have both played a major role in the development and manufacturing of breakthrough implantable devices Continue reading →

New long-term data from the CSP 474 trial offers a challenge to some of the conventional wisdom around graft choice in CABG surgery and may further the debate over recent guideline recommendations. Presenting long-term mortality numbers from the VA study at the European Association for Cardio-Thoracic Surgery (EACTS) 2022 conference last week, researchers showed that when an adjunctive graft was needed in patients with multivessel coronary artery disease, use of the radial artery instead of a saphenous vein did not confer a survival advantage. Even with the new results, though, surgeons should, when possible, be aiming to perform multiarterial grafts in patients with multivessel coronary disease, say researchers, although surgical skills should drive decisions as to the optimal conduit. Continue reading →